Abstract
Chronic suppurative otitis media (CSOM) is an advanced, persistent form of otitis media (OM) which is characterized by chronic inflammation of the middle ear cleft (MEC), in the presence of a non-intact tympanic membrane leading to frequent and recurrent otorrhea from the ear. CSOM is most prevalent in South East Asia and the Western Pacific and among indigenous populations of North America. The management of CSOM has two principal aims: First, to eradicate infection and hence reduce morbidity and mortality, second, to close the tympanic membrane perforation to reduce hearing loss and risk of reinfection of the middle ear (ME). Recognition of cases that are better managed surgically should be prompt to avoid delayed treatment and reduce morbidity. In some cases this means instituting treatment to stop discharge from the ear before it can be established whether the patient has either active mucosal chronic otitis media (COM) or active squamous COM (cholesteatoma) both of which require surgical intervention. Emerging evidence suggests that biofilms play an important role in the disease process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Acuin J. Chronic suppurative otitis media—burden of illness and management options. Geneva: WHO; 2004.
Roland PS. Chronic suppurative otitis media: a clinical overview. Ear Nose Throat J. 2002;81(8):8–10.
Verhoeff M, van der Veen EL, Rovers MM, Sanders EA, Schilder AG. Chronic suppurative otitis media: a review. Int J Paediatr Otorhinolaryngol. 2005;70:1–12.
Leiberman A, Fliss DM, Dagan R. Medical treatment of chronic suppurative otitis media without cholesteatoma in children—a two-year follow-up. Int J Paediatr Otorhinolaryngol. 1992;24:25–33.
Bluestone CD. Epidemiology and pathogenesis of CSOM: implications for prevention and treatment. Int J Paediatr Otorhinolaryngol. 1998;42(3):207–23.
1996 W. Prevention of hearing impairment from chronic Otitis media. 1996.
Harvey J, Coates PSM, Leach AJ, Couzos S. Otitis media in Aboriginal children: tackling a major health problem. Med J Aust. 2002;177(4):177–8.
Coates HJ. Chronic suppurative otitis media in indigenous populations: the Australian Aborigine. Ear Nose Throat J. 2002;81(8):11–2.
Wintermeyer SM, Nahata M. Chronic suppurative otitis media. Ann Pharmacother. 1994;28(111):2–9.
Adair-Bischoff CE, Sauve R. Environmental tobacco smoke in middle ear disease in pre-school age children. Arch Pediatr Adolesc Med. 1998;152(2):127–33.
van der Veen EL, Schilder AG, van Heerbeek N, Verhoeff M, Zielhuis GA, Rovers MM. Predictors of chronic suppurative otitis media in children. Arch Otolaryngol Head Neck Surg. 2006;132:1115–8.
Kay DJ, Nelson M, Rosenfeld RM. Meta-analysis of tympanostomy tube sequelae. Otolaryngol Head Neck Surg. 2001;124(4):374–80. (Brooklyn, New York)
Kvaerner KJ, Tambs K, Harris JR, Magnus P. Distribution and heritability of recurrent ear infections. Annals Otol Rhinol Laryngol. 1997;106(8):624–32.
Review genetic susceptibility to otitis media in childhood.
Casselbrant ML, Mandel EM, Fall PA, Rockette HE, Kurs-Lasky M, Bluestone CD, Ferrell RE. The heritability of otitis media: a twin and triplet study. JAMA. 1999;282(22):2125–30.
Segade F, Daly KA, Allred D, Hicks PJ, Cox M, Brown M, Hardisty-Hughes RE, Brown SD, Rich SS, Bowden DW. Association of the FBXO11 gene with COME/ROM in the Minnesota COME/ROM family study. Arch Otolaryngol Head Neck Surg. 2006;132(7):729–33.
Rye MS, Wiertsema SP, Scaman ES, Oommen J, Sun W, Francis RW, Ang W, Pennell CE, Burgner D, Richmond P, Vijayasekaran S, Coates HL, Brown SD, Blackwell JM, Jamieson SE. FBXO11, a regulator of the TGFb pathway, is associated with severe otitis media in Western Australian children. Genes Immun. 2011;12:352–9.
Rye MS, Blackwell JM, Jamieson SE. Genetic susceptibility to otitis media in childhood. Laryngoscope. 2012;122(3):665–75.
Rye MS, Warrington NM, Scaman ES, Vijayasekaran S, Coates HL, Anderson D, Pennell CE, Blackwell JM, Jamieson SE. Genome-wide association study to identify the genetic determinants of otitis media susceptibility in childhood. PLoS ONE. 2012;7(10):e48215.
Massa HM CA, Lehmann D. Otitis media: viruses, bacteria, biofilms and vaccines. Med J Aust. 2009;191 (9 Suppl):S44–9.
Induharan R. Antibiotics in chronic suppurative otitis media: a bacteriologic study. Ann Otol Rhinol Laryngol. 1999;108(5):440–5.
Fliss DM. Aerobic bacteriology of chronic suppurative otitis media without cholesteatoma in children. Ann Otol Rhinol Laryngol. 1992;101:866–9.
Margaret A. Kenna CB. Microbiology of chronic suppurative otitis media in children. Pediatr Infect Dis. 1986;86:223–5.
Costerton JW, Geesey G, Cheng KJ. How bacteria stick. Sci Am. 1978;238(1):86–95.
Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167–93.
Coates H, Langlands J, Filion P, Keil AD, et al. The role of chronic infection in children with otitis media with effusion: evidence for intracellular persistence of bacteria. Otolaryngol Head Neck Surg. 2008;138:778–81.
Ruth BT, Rigby PJ, Selma PW, Filion P, Langlands J, Harvey LC, Vijayasekaran S, Keil AD, Richmond PC. Multi-species bacterial biofilm and intracellular infection in otitis media. BMC Pediatr. 2011;11:94. (1996, WHO)
Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, Forbes M, Greenberg DP, Dice B, Burrows A, Wackym PA, Stoodley P, Post JC, Ehrlich GD, Kerschner JE. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA. 2006;296(2):202–11.
Barakate M, Becknham E, Curotta J, Da Cruz M. Bacterial biofilm adherence to middle-ear ventilation tubes: scanning electron micrograph images and literature review. J Laryngol Otol. 2007;121:993–7.
Krause PJ, Owens NJ, Nightingale CH, Kilmek JJ, Lehmann WB, Quintillani R. Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media. J Infect Dis. 1982;145(6):815–21.
Berry JA, Biedlingmaier JF, Whelan PJ. In vitro resistance to bacterial biofilm formation on coated fluoroplastic tympanostomy tubes. Otolaryngol Head Neck Surg. 2000;123:246–51.
Acuin JM, Chiong C, Yang N. Surgery for chronically discharging ears with underlying eardrum perforations. Cochrane Database. 2009.
Leach A, Wood Y, Gadil E, Stubbs E, Morris P. Topical ciprofloxin versus topical framycetin-gramicidin-dexamethasone in Australian Aboriginal children with recently treated chronic suppurative otitis media a randomized controlled trial. Pediatr Infect Dis J. 2008;27(8):692–8.
Macfadyen CA, Acuin JM, Gamble CL. Systemic antibiotics versus topical treatments for chronically discharging ears with underlying eardrum perforations (Review). Cochrane Database. 2009.
Leach AJ, Morris PS. Antibiotics for the prevention of acute and chronic suppurative otitis media in children (Review). Cochrane Database. 2006.
Haynes DS. Surgery for chronic ear disease. Ear Nose Throat J. 2001;80(6):S8–11.
OTOLARYNGOLOGY TCOCOHOTAAOOA. Standard classification for surgery of chronic ear infection. Arch Otolaryngol Head Neck Surg. 1965;81:204–5.
Storrs LA. Myringoplasty with the use of fascia grafts. Arch Otolaryngol Head Neck Surg. 1961;71:45–9.
Haynes DS, Vos JD, Labadie RF. Acellular allograft dermal matrix for tympanoplasty. Curr Opin Otolaryngol Head Neck Surg. 2006;13(5):283–6.
Bennett M, Warren F, Haynes D. Indications and technique in mastoidectomy. Otolaryngol Clin North Am. 2006;39:1095–113.
Stankovic MD. Audiologic results of surgery for cholesteatoma: short- and long-term follow up of influential factors. Otolo Neurotol. 2008;29:933.
Koch WM. Tympanoplasty in children. The Boston Children’s Hospital experience. Arch Otolaryngol Head Neck Surg. 1990;116:35–40.
Mishiro Y, Sakagami M, Takahashi Y, Kitahara T, Kajikawa H, Kubo T. Tympanoplasty with and without mastoidectomy for non-cholesteatomatous chronic otitis media. Eur Arch Otorhinolaryngol. 2001;258(1):13–5.
Vartiainen E. Tympanomastoidectomy for chronic otitis media without cholesteatoma. Otolaryngol Head Neck Surg. 1992;106(3):230–4.
Vrabec JT, Deskin RW, Grady JJ. Meta-analysis of pediatric tympanoplasty. Arch Otolaryngol Head Neck Surg. 1999;125(5):530–4.
Thornton RB, Wiertsema SP, Kirkham LA, Rigby PJ, Vijayasekaran S, Coates HL, Richmond PC. Neutrophil extracellular traps and bacterial biofilms in middle ear effusion of children with recurrent acute Otitis media—a potential treatment target. PLOS ONE. 2013;8(2):e53837.
Fireman F, Black SB, Shinefield HR, Lee J, Lewis E, Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis. 2003;22(1):10–7.
Mackenzie GA, Carapetis JR, Leach AJ, Morris PS. Pneumococcal vaccination and otitis media in Australian Aboriginal infants: comparison of two birth cohorts before and after introduction of vaccination. BioMed Central. 2009;19:14.
Kanemaru S, Umeda H, Kitani Y, Nakamura T, Hirano S, Ito J. Regenerative treatment for tympanic membrane perforation. J Otol Neurotol. 2011;32(8):1218–23.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Prunty, S., Ha, J., Vijayasekaran, S. (2015). Management of Chronic Suppurative Otitis Media. In: Preciado, D. (eds) Otitis Media: State of the art concepts and treatment. Springer, Cham. https://doi.org/10.1007/978-3-319-17888-2_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-17888-2_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17887-5
Online ISBN: 978-3-319-17888-2
eBook Packages: MedicineMedicine (R0)